{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T03:47:52Z","timestamp":1794628072484,"version":"4.9.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Cardiac hypertrophy is a cellular process characterized by the increased size of cardiomyocytes in response to a high workload or stress. 17-beta estradiol (E2) has cardioprotective and anti-hypertrophic effects by maintaining mitochondrial network and function. MUL1 is a mitochondrial ubiquitin ligase directly involved in the control of mitochondrial fission and mitophagy. Studies from our group and others have previously shown that cardiomyocyte hypertrophy is associated with mitochondrial fission and dysfunction. These findings led us to study in vitro whether E2 regulates MUL1 to prevent cardiac hypertrophy, mitochondrial fission, and dysfunction induced by the catecholamine norepinephrine (NE). Our results showed that NE induces hypertrophy in cultured rat cardiomyocytes. Pre-treatment with E2 (10-100\u2009nM) prevented the NE-dependent increases in cell perimeter and the hypertrophic stress markers ANP and BNP at both the protein and mRNA levels. NE induced the fragmentation of the mitochondrial network and reduced ATP levels, effects that were both prevented by E2. <jats:italic>In<\/jats:italic> s<jats:italic>ilico<\/jats:italic> analysis suggested a putative binding site for estrogen receptors on the MUL1 gene promoter. In accordance with this finding, E2 prevented increases in MUL1 mRNA and protein levels induced by NE. Our data also showed that a siRNA MUL1 knockdown counteracted NE-induced cardiomyocyte hypertrophy and mitochondrial dysfunction, mirroring the protective effect triggered by E2. In contrast, a MUL1 adenovirus did not prevent the E2 protection from cardiomyocyte hypertrophy. Further, in vivo analysis in a transgenic mouse model overexpressing MUL1 revealed that only young male mice overexpressed the protein. Consequently, they exhibited increased levels of the hypertrophic marker ANP, an elevated heart weight, and larger cardiomyocyte size. Therefore, our data demonstrate that 17-beta estradiol prevents cardiac myocyte hypertrophy by regulating MUL1.<\/jats:p>","DOI":"10.1038\/s41419-025-07389-3","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T13:01:21Z","timestamp":1739970081000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["17-beta estradiol prevents cardiac myocyte hypertrophy by regulating mitochondrial E3 ubiquitin ligase 1"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9338-6795","authenticated-orcid":false,"given":"Ximena","family":"Calle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3298-2622","authenticated-orcid":false,"given":"Valeria","family":"Garrido-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7083-449X","authenticated-orcid":false,"given":"Brenda","family":"Becerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3492-8283","authenticated-orcid":false,"given":"Mayarling F.","family":"Troncoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8233-4917","authenticated-orcid":false,"given":"Juan Francisco","family":"Silva-Ag\u00fcero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6091-6745","authenticated-orcid":false,"given":"Emanuel","family":"Guajardo-Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7726-8801","authenticated-orcid":false,"given":"Leslye","family":"Venegas-Zamora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4764-6680","authenticated-orcid":false,"given":"Erik","family":"Lopez-Gallardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1185-3401","authenticated-orcid":false,"given":"Felipe","family":"Mu\u00f1oz-C\u00f3rdova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5790-3200","authenticated-orcid":false,"given":"Fernanda","family":"Fredericksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7229-2545","authenticated-orcid":false,"given":"Sebastian","family":"Aedo-Cares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7297-5849","authenticated-orcid":false,"given":"Allan","family":"Pe\u00f1aloza-Ot\u00e1rola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7286-8154","authenticated-orcid":false,"given":"Angelica","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2189-9775","authenticated-orcid":false,"given":"Angel","family":"Raya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8873-9381","authenticated-orcid":false,"given":"Vinicius","family":"Maracaja-Coutinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5174-6545","authenticated-orcid":false,"given":"Mario","family":"Chiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0080-6472","authenticated-orcid":false,"given":"Valentina","family":"Parra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4258-1483","authenticated-orcid":false,"given":"Sergio","family":"Lavandero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"key":"7389_CR1","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/cphy.c140055","volume":"6","author":"E Tanai","year":"2015","unstructured":"Tanai E, Frantz S. Pathophysiology of heart failure. Compr Physiol. 2015;6:187\u2013214.","journal-title":"Compr Physiol"},{"key":"7389_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2021.166208","volume":"1867","author":"A Del Campo","year":"2021","unstructured":"Del Campo A, Perez G, Castro PF, Parra V, Verdejo HE. Mitochondrial function, dynamics and quality control in the pathophysiology of hfpef. Biochim Biophys Acta Mol Basis Dis. 2021;1867:166208 https:\/\/doi.org\/10.1016\/j.bbadis.2021.166208","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"7389_CR3","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1136\/heartjnl-2022-322164","volume":"110","author":"DJ Doherty","year":"2024","unstructured":"Doherty DJ, Docherty KF, Gardner RS. Review of the national institute for health and care excellence guidelines on chronic heart failure. Heart. 2024;110:466\u201375. https:\/\/doi.org\/10.1136\/heartjnl-2022-322164","journal-title":"Heart"},{"key":"7389_CR4","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.3390\/cells12131780","volume":"12","author":"F Bazgir","year":"2023","unstructured":"Bazgir F, Nau J, Nakhaei-Rad S, Amin E, Wolf MJ, Saucerman JJ, et al. The microenvironment of the pathogenesis of cardiac hypertrophy. Cells. 2023;12:1780. https:\/\/doi.org\/10.3390\/cells12131780","journal-title":"Cells"},{"key":"7389_CR5","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/s41569-023-00887-x","volume":"20","author":"J Ritterhoff","year":"2023","unstructured":"Ritterhoff J, Tian R. Metabolic mechanisms in physiological and pathological cardiac hypertrophy: new paradigms and challenges. Nat Rev Cardiol. 2023;20:812\u201329. https:\/\/doi.org\/10.1038\/s41569-023-00887-x","journal-title":"Nat Rev Cardiol"},{"key":"7389_CR6","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","volume":"15","author":"M Nakamura","year":"2018","unstructured":"Nakamura M, Sadoshima J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat Rev Cardiol. 2018;15:387\u2013407. https:\/\/doi.org\/10.1038\/s41569-018-0007-y","journal-title":"Nat Rev Cardiol"},{"key":"7389_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s12265-019-09907-z","volume":"13","author":"J Wu","year":"2020","unstructured":"Wu J, Dai F, Li C, Zou Y. Gender differences in cardiac hypertrophy. J Cardiovasc Transl Res. 2020;13:73\u201384. https:\/\/doi.org\/10.1007\/s12265-019-09907-z","journal-title":"J Cardiovasc Transl Res"},{"key":"7389_CR8","first-page":"S34","volume":"20","author":"E Agabiti-Rosei","year":"2002","unstructured":"Agabiti-Rosei E, Muiesan ML. Left ventricular hypertrophy and heart failure in women. J Hypertens Suppl. 2002;20:S34\u20138.","journal-title":"J Hypertens Suppl"},{"key":"7389_CR9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.pharmthera.2012.03.007","volume":"135","author":"AA Knowlton","year":"2012","unstructured":"Knowlton AA, Lee AR. Estrogen and the cardiovascular system. Pharmacol Ther. 2012;135:54\u201370. https:\/\/doi.org\/10.1016\/j.pharmthera.2012.03.007","journal-title":"Pharmacol Ther"},{"key":"7389_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.maturitas.2017.11.006","volume":"108","author":"V Subramanya","year":"2018","unstructured":"Subramanya V, Zhao D, Ouyang P, Lima JA, Vaidya D, Ndumele CE, et al. Sex hormone levels and change in left ventricular structure among men and post-menopausal women: the multi-ethnic study of atherosclerosis (mesa). Maturitas. 2018;108:37\u201344. https:\/\/doi.org\/10.1016\/j.maturitas.2017.11.006","journal-title":"Maturitas"},{"key":"7389_CR11","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1291\/hypres.25.153","volume":"25","author":"Y Miya","year":"2002","unstructured":"Miya Y, Sumino H, Ichikawa S, Nakamura T, Kanda T, Kumakura H, et al. Effects of hormone replacement therapy on left ventricular hypertrophy and growth-promoting factors in hypertensive postmenopausal women. Hypertens Res. 2002;25:153\u20139. https:\/\/doi.org\/10.1291\/hypres.25.153","journal-title":"Hypertens Res"},{"key":"7389_CR12","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/s0008-6363(01)00526-0","volume":"53","author":"FA Babiker","year":"2002","unstructured":"Babiker FA, De Windt LJ, van Eickels M, Grohe C, Meyer R, Doevendans PA. Estrogenic hormone action in the heart: regulatory network and function. Cardiovasc Res. 2002;53:709\u201319. https:\/\/doi.org\/10.1016\/s0008-6363(01)00526-0","journal-title":"Cardiovasc Res"},{"key":"7389_CR13","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1200\/JCO.2000.18.17.3172","volume":"18","author":"CK Osborne","year":"2000","unstructured":"Osborne CK, Zhao H, Fuqua SA. Selective estrogen receptor modulators: structure, function, and clinical use. J Clin Oncol. 2000;18:3172\u201386. https:\/\/doi.org\/10.1200\/JCO.2000.18.17.3172","journal-title":"J Clin Oncol"},{"key":"7389_CR14","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s13311-019-00766-9","volume":"16","author":"JK Russell","year":"2019","unstructured":"Russell JK, Jones CK, Newhouse PA. The role of estrogen in brain and cognitive aging. Neurotherapeutics. 2019;16:649\u201365. https:\/\/doi.org\/10.1007\/s13311-019-00766-9","journal-title":"Neurotherapeutics"},{"key":"7389_CR15","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqaa030","volume":"161","author":"CL Faltas","year":"2020","unstructured":"Faltas CL, LeBron KA, Holz MK. Unconventional estrogen signaling in health and disease. Endocrinology. 2020;161:bqaa030 https:\/\/doi.org\/10.1210\/endocr\/bqaa030","journal-title":"Endocrinology"},{"key":"7389_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.968373","volume":"10","author":"E Guajardo-Correa","year":"2022","unstructured":"Guajardo-Correa E, Silva-Aguero JF, Calle X, Chiong M, Henriquez M, Garcia-Rivas G, et al. Estrogen signaling as a bridge between the nucleus and mitochondria in cardiovascular diseases. Front Cell Dev Biol. 2022;10:968373. https:\/\/doi.org\/10.3389\/fcell.2022.968373","journal-title":"Front Cell Dev Biol"},{"key":"7389_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsbmb.2014.11.009","volume":"147","author":"C Rattanasopa","year":"2015","unstructured":"Rattanasopa C, Phungphong S, Wattanapermpool J, Bupha-Intr T. Significant role of estrogen in maintaining cardiac mitochondrial functions. J Steroid Biochem Mol Biol. 2015;147:1\u20139. https:\/\/doi.org\/10.1016\/j.jsbmb.2014.11.009","journal-title":"J Steroid Biochem Mol Biol"},{"key":"7389_CR18","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1242\/jcs.139394","volume":"127","author":"C Pennanen","year":"2014","unstructured":"Pennanen C, Parra V, Lopez-Crisosto C, Morales PE, Del Campo A, Gutierrez T, et al. Mitochondrial fission is required for cardiomyocyte hypertrophy mediated by a ca2+-calcineurin signaling pathway. J Cell Sci. 2014;127:2659\u201371. https:\/\/doi.org\/10.1242\/jcs.139394","journal-title":"J Cell Sci"},{"key":"7389_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2019.09.006","volume":"71","author":"PE Morales","year":"2020","unstructured":"Morales PE, Arias-Duran C, Avalos-Guajardo Y, Aedo G, Verdejo HE, Parra V, et al. Emerging role of mitophagy in cardiovascular physiology and pathology. Mol Aspects Med. 2020;71:100822. https:\/\/doi.org\/10.1016\/j.mam.2019.09.006","journal-title":"Mol Aspects Med"},{"key":"7389_CR20","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1038\/s41418-020-0522-3","volume":"27","author":"C Sotomayor-Flores","year":"2020","unstructured":"Sotomayor-Flores C, Rivera-Mejias P, Vasquez-Trincado C, Lopez-Crisosto C, Morales PE, Pennanen C, et al. Angiotensin-(1-9) prevents cardiomyocyte hypertrophy by controlling mitochondrial dynamics via mir-129-3p\/pkia pathway. Cell Death Differ. 2020;27:2586\u2013604. https:\/\/doi.org\/10.1038\/s41418-020-0522-3","journal-title":"Cell Death Differ"},{"key":"7389_CR21","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.cub.2007.12.038","volume":"18","author":"M Neuspiel","year":"2008","unstructured":"Neuspiel M, Schauss AC, Braschi E, Zunino R, Rippstein P, Rachubinski RA, et al. Cargo-selected transport from the mitochondria to peroxisomes is mediated by vesicular carriers. Curr Biol. 2008;18:102\u20138. https:\/\/doi.org\/10.1016\/j.cub.2007.12.038","journal-title":"Curr Biol"},{"key":"7389_CR22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.mito.2016.03.007","volume":"28","author":"J Peng","year":"2016","unstructured":"Peng J, Ren KD, Yang J, Luo XJ. Mitochondrial e3 ubiquitin ligase 1: a key enzyme in regulation of mitochondrial dynamics and functions. Mitochondrion. 2016;28:49\u201353. https:\/\/doi.org\/10.1016\/j.mito.2016.03.007","journal-title":"Mitochondrion"},{"key":"7389_CR23","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/embor.2009.86","volume":"10","author":"E Braschi","year":"2009","unstructured":"Braschi E, Zunino R, McBride HM. Mapl is a new mitochondrial sumo e3 ligase that regulates mitochondrial fission. EMBO Rep. 2009;10:748\u201354. https:\/\/doi.org\/10.1038\/embor.2009.86","journal-title":"EMBO Rep"},{"key":"7389_CR24","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/cr.2012.38","volume":"22","author":"S Bae","year":"2012","unstructured":"Bae S, Kim SY, Jung JH, Yoon Y, Cha HJ, Lee H, et al. Akt is negatively regulated by the mulan e3 ligase. Cell Res. 2012;22:873\u201385. https:\/\/doi.org\/10.1038\/cr.2012.38","journal-title":"Cell Res"},{"key":"7389_CR25","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.cmet.2012.10.013","volume":"16","author":"D Attaix","year":"2012","unstructured":"Attaix D, Taillandier D. The missing link: Mul1 signals mitophagy and muscle wasting. Cell Metab. 2012;16:551\u20132. https:\/\/doi.org\/10.1016\/j.cmet.2012.10.013","journal-title":"Cell Metab"},{"key":"7389_CR26","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.molcel.2015.08.001","volume":"59","author":"J Prudent","year":"2015","unstructured":"Prudent J, Zunino R, Sugiura A, Mattie S, Shore GC, McBride HM. Mapl sumoylation of drp1 stabilizes an er\/mitochondrial platform required for cell death. Mol Cell. 2015;59:941\u201355. https:\/\/doi.org\/10.1016\/j.molcel.2015.08.001","journal-title":"Mol Cell"},{"key":"7389_CR27","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1016\/j.bbadis.2017.07.034","volume":"1863","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, Ponnusamy M, Liu C, Tian J, Dong Y, Gao J, et al. Mir-485-5p modulates mitochondrial fission through targeting mitochondrial anchored protein ligase in cardiac hypertrophy. Biochim Biophys Acta Mol Basis Dis. 2017;1863:2871\u201381. https:\/\/doi.org\/10.1016\/j.bbadis.2017.07.034","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"7389_CR28","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/iub.2657","volume":"74","author":"X Calle","year":"2022","unstructured":"Calle X, Garrido-Moreno V, Lopez-Gallardo E, Norambuena-Soto I, Martinez D, Penaloza-Otarola A, et al. Mitochondrial e3 ubiquitin ligase 1 (mul1) as a novel therapeutic target for diseases associated with mitochondrial dysfunction,. IUBMB Life. 2022;74:850\u201365. https:\/\/doi.org\/10.1002\/iub.2657","journal-title":"IUBMB Life"},{"key":"7389_CR29","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1161\/CIRCRESAHA.117.311522","volume":"122","author":"V Parra","year":"2018","unstructured":"Parra V, Altamirano F, Hernandez-Fuentes CP, Tong D, Kyrychenko V, Rotter D, et al. Down syndrome critical region 1 gene, rcan1, helps maintain a more fused mitochondrial network. Circ Res. 2018;122:e20\u2013e33. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.311522","journal-title":"Circ Res"},{"key":"7389_CR30","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1113\/JP271301","volume":"594","author":"C Vasquez-Trincado","year":"2016","unstructured":"Vasquez-Trincado C, Garcia-Carvajal I, Pennanen C, Parra V, Hill JA, Rothermel BA, et al. Mitochondrial dynamics, mitophagy and cardiovascular disease. J Physiol. 2016;594:509\u201325. https:\/\/doi.org\/10.1113\/JP271301","journal-title":"J Physiol"},{"key":"7389_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.564781","volume":"12","author":"J Mehta","year":"2021","unstructured":"Mehta J, Kling JM, Manson JE. Risks, benefits, and treatment modalities of menopausal hormone therapy: Current concepts. Front Endocrinol (Lausanne). 2021;12:564781. https:\/\/doi.org\/10.3389\/fendo.2021.564781","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7389_CR32","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nprot.2012.150","volume":"8","author":"X Lian","year":"2013","unstructured":"Lian X, Zhang J, Azarin SM, Zhu K, Hazeltine LB, Bao X, et al. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating wnt\/beta-catenin signaling under fully defined conditions. Nat Protoc. 2013;8:162\u201375. https:\/\/doi.org\/10.1038\/nprot.2012.150","journal-title":"Nat Protoc"},{"key":"7389_CR33","doi-asserted-by":"publisher","first-page":"26339","DOI":"10.1074\/jbc.M414409200","volume":"280","author":"A Pedram","year":"2005","unstructured":"Pedram A, Razandi M, Aitkenhead M, Levin ER. Estrogen inhibits cardiomyocyte hypertrophy in vitro. Antagonism of calcineurin-related hypertrophy through induction of mcip1. J Biol Chem. 2005;280:26339\u201348. https:\/\/doi.org\/10.1074\/jbc.M414409200","journal-title":"J Biol Chem"},{"key":"7389_CR34","doi-asserted-by":"publisher","first-page":"81","DOI":"10.7150\/ijbs.28304","volume":"15","author":"H Pei","year":"2019","unstructured":"Pei H, Wang W, Zhao D, Su H, Su G, Zhao Z. G protein-coupled estrogen receptor 1 inhibits angiotensin ii-induced cardiomyocyte hypertrophy via the regulation of pi3k-akt-mtor signalling and autophagy. Int J Biol Sci. 2019;15:81\u201392. https:\/\/doi.org\/10.7150\/ijbs.28304","journal-title":"Int J Biol Sci"},{"key":"7389_CR35","doi-asserted-by":"publisher","first-page":"C310","DOI":"10.1152\/ajpcell.00060.2017","volume":"314","author":"GK Goncalves","year":"2018","unstructured":"Goncalves GK, Scalzo S, Alves AP, Agero U, Guatimosim S, Reis AM. Neonatal cardiomyocyte hypertrophy induced by endothelin-1 is blocked by estradiol acting on gper. Am J Physiol Cell Physiol. 2018;314:C310\u2013C322. https:\/\/doi.org\/10.1152\/ajpcell.00060.2017","journal-title":"Am J Physiol Cell Physiol"},{"key":"7389_CR36","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.mce.2017.11.004","volume":"470","author":"N Hoa","year":"2018","unstructured":"Hoa N, Ge L, Korach KS, Levin ER. Estrogen receptor beta maintains expression of klf15 to prevent cardiac myocyte hypertrophy in female rodents. Mol Cell Endocrinol. 2018;470:240\u201350. https:\/\/doi.org\/10.1016\/j.mce.2017.11.004","journal-title":"Mol Cell Endocrinol"},{"key":"7389_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.839005","volume":"13","author":"P Chen","year":"2022","unstructured":"Chen P, Li B, Ou-Yang L. Role of estrogen receptors in health and disease. Front Endocrinol (Lausanne). 2022;13:839005 https:\/\/doi.org\/10.3389\/fendo.2022.839005","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7389_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1072315","volume":"11","author":"C Vasquez-Trincado","year":"2023","unstructured":"Vasquez-Trincado C, Navarro-Marquez M, Morales PE, Westermeier F, Chiong M, Parra V, et al. Myristate induces mitochondrial fragmentation and cardiomyocyte hypertrophy through mitochondrial e3 ubiquitin ligase mul1. Front Cell Dev Biol. 2023;11:1072315. https:\/\/doi.org\/10.3389\/fcell.2023.1072315","journal-title":"Front Cell Dev Biol"},{"key":"7389_CR39","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1016\/j.lfs.2007.04.003","volume":"80","author":"L Fang","year":"2007","unstructured":"Fang L, Moore XL, Gao XM, Dart AM, Lim YL, Du XJ. Down-regulation of mitofusin-2 expression in cardiac hypertrophy in vitro and in vivo. Life Sci. 2007;80:2154\u201360. https:\/\/doi.org\/10.1016\/j.lfs.2007.04.003","journal-title":"Life Sci"},{"key":"7389_CR40","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1177\/1074248410385683","volume":"16","author":"H Yu","year":"2011","unstructured":"Yu H, Guo Y, Mi L, Wang X, Li L, Gao W. Mitofusin 2 inhibits angiotensin ii-induced myocardial hypertrophy. J Cardiovasc Pharmacol Ther. 2011;16:205\u201311. https:\/\/doi.org\/10.1177\/1074248410385683","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"7389_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2021.101576","volume":"35","author":"A Maas","year":"2021","unstructured":"Maas A. Hormone therapy and cardiovascular disease: benefits and harms. Best Pract Res Clin Endocrinol Metab. 2021;35:101576 https:\/\/doi.org\/10.1016\/j.beem.2021.101576","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"7389_CR42","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1210\/clinem\/dgab042","volume":"106","author":"CL Shufelt","year":"2021","unstructured":"Shufelt CL, Manson JE. Menopausal hormone therapy and cardiovascular disease: the role of formulation, dose, and route of delivery. J Clin Endocrinol Metab. 2021;106:1245\u201354. https:\/\/doi.org\/10.1210\/clinem\/dgab042","journal-title":"J Clin Endocrinol Metab"},{"key":"7389_CR43","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s004410100358","volume":"304","author":"A Galvez","year":"2001","unstructured":"Galvez A, Morales MP, Eltit JM, Ocaranza P, Carrasco L, Campos X, et al. A rapid and strong apoptotic process is triggered by hyperosmotic stress in cultured rat cardiac myocytes. Cell Tissue Res. 2001;304:279\u201385. https:\/\/doi.org\/10.1007\/s004410100358","journal-title":"Cell Tissue Res"},{"key":"7389_CR44","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2337\/db13-0340","volume":"63","author":"V Parra","year":"2014","unstructured":"Parra V, Verdejo HE, Iglewski M, Del Campo A, Troncoso R, Jones D, et al. Insulin stimulates mitochondrial fusion and function in cardiomyocytes via the akt-mtor-nfkappab-opa-1 signaling pathway. Diabetes. 2014;63:75\u201388. https:\/\/doi.org\/10.2337\/db13-0340","journal-title":"Diabetes"},{"key":"7389_CR45","doi-asserted-by":"publisher","first-page":"W175","DOI":"10.1093\/nar\/gkac199","volume":"50","author":"Z Zou","year":"2022","unstructured":"Zou Z, Ohta T, Miura F, Oki S. Chip-atlas 2021 update: a data-mining suite for exploring epigenomic landscapes by fully integrating chip-seq, atac-seq and bisulfite-seq data. Nucleic Acids Res. 2022;50:W175\u2013W182. https:\/\/doi.org\/10.1093\/nar\/gkac199","journal-title":"Nucleic Acids Res"},{"key":"7389_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41597-019-0193-4","volume":"6","author":"SA Ochsner","year":"2019","unstructured":"Ochsner SA, Abraham D, Martin K, Ding W, McOwiti A, Kankanamge W, et al. The signaling pathways project, an integrated \u2018omics knowledgebase for mammalian cellular signaling pathways. Sci Data. 2019;6:252. https:\/\/doi.org\/10.1038\/s41597-019-0193-4","journal-title":"Sci Data"},{"key":"7389_CR47","unstructured":"E Taucher, Bioestadistica, Primera ed., Editorial Universitaria (1997)."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07389-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07389-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07389-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T13:01:25Z","timestamp":1739970085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07389-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7389"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07389-3","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,19]]},"assertion":[{"value":"19 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All cell and animal procedures were approved by the Ethics Committee of the Faculty of Chemical and Pharmaceutical Sciences, University of Chile (Protocol Numbers 20351 CYQ-UCh and CBE 2020-08, respectively).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"111"}}